Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5813 posts found.

Moderna could offer better defence against Delta variant than Pfizer

August 10, 2021 Manufacturing and Production

Pfizer-BioNTech’s mRNA could be less effective than Moderna’s against the Delta variant of COVID-19. In a study of more than …
News
pfizer_building_logo2_1

Scotland approves Merck and Pfizer’s Bavencio for bladder cancer

August 10, 2021 Manufacturing and Production

Merck and Pfizer’s Bavencio (avelumab) has been approved by approved by the Scottish Medicines Consortium (SMC) for use via NHS …
News

Novartis set to launch new Zolgensma trial to expand use

August 3, 2021 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Novartis has announced that it will launch a new Phase III study to expand the use of Zolgensma – the …
News

Cannabis-based oral spray could kill brain tumours, study to launch next year

August 3, 2021 Manufacturing and Production, Medical Communications, Research and Development

The NHS alongside cancer charities are set to launch a clinical trial to investigate the effects of a cannabis-based oral …
News
sanofi_hq__boetie_hall_small_

Sanofi to buy Translate Bio for $3.2 billion

August 3, 2021 Manufacturing and Production

Sanofi has agreed to buy U.S. biotech company Translate Bio in a $3.2 billion deal.This is part of Sanofi’s goal …
News
nice_new_london_office_internal_2_88

NICE approves UCB’s bimekizumab through expedited review process

August 3, 2021 Manufacturing and Production

NICE has published draft guidance on the first treatment to use its new review process, recommending UCB’s bimekizumab for treating …
News
fda_building_62

FDA approves AstraZeneca’s anifrolumab for treating lupus

August 3, 2021 Manufacturing and Production

The FDA has approved Saphnelo (anifrolumab) for the treatment of moderate-to-severe systemic lupus erythematosus (SLE), the most common form of …
News

CanSino’s inhaled COVID vaccine performs well in early trials

July 28, 2021 Manufacturing and Production, Research and Development

Early-stage data, published in The Lancet on Monday, has shown CanSino Biologic’s inhaled COVID-19 vaccine was able to stimulate neutralising …
News
astrazeneca_sign_sky

AstraZeneca & Regeneron to develop small molecule obesity treatment

July 28, 2021 Manufacturing and Production, Research and Development

AstraZeneca and Regeneron have announced a collaboration to research, develop and commercialise small molecule compounds directed against the GPR75 target …
News

Tokyo daily COVID cases hit record high

July 27, 2021 Manufacturing and Production, Medical Communications

On Tuesday Tokyo reported 2,848 daily coronavirus infections, the city’s highest rate since the pandemic began. The new infection record …
News
andrei_r_-_shutterstock_1935537274_720

Byondis and Glycotope to collaborate on antibodies against novel GlycoTargets

July 27, 2021 Manufacturing and Production

Byondis and Glycotope have entered into a platform access agreement to discover and develop antibodies that target specific tumour-associated protein/carbohydrate …
News

BioNTech set to develop first mRNA malaria vaccine

July 27, 2021 Manufacturing and Production, Research and Development

Buliding on the success of its COVID-19 vaccine, BioNTech has announced the development of the first mRNA vaccine against malaria, …
News

Antibodies from Sinovac’s COVID-19 vaccine fade after 6 months, study finds

July 27, 2021 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

A Chinese laboratory study has found that antibodies from Sinovac Biotech’s COVID-19 vaccine drop below a key threshold around six …
News

Purdue Pharma votes for bankruptcy plan to pay for its role in US opioid crisis

July 27, 2021 Manufacturing and Production

Oxycontin makers Purdue Pharma have voted in favour of its bankruptcy reorganisation plan that will provide billions of dollars to …
News
cdc-un8tv9pw2ik-unsplash_1

Two shots of Pfizer or AstraZeneca vaccine are effective against Delta variant

July 22, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

A new study has shown that two shots of either Pfizer or AstraZeneca’s COVID-19 vaccine are nearly as effective against …
News

Latest content

Sanofi shares results from phase 2 trial for frexalimab in MS treatment

July 1, 2024

EMA accepts AstraZeneca’s regulatory submission for sipavibart for COVID-19 prevention

July 1, 2024

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024